Reta glucagon-like peptide-1 (GLP-1) receptor agonists offer a groundbreaking strategy to diabetes management. These innovative therapies operate by mimicking the physiological actions of GLP-1, a hormone produced by https://worldsocialindex.com/story5856850/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes